Functional and genetic studies of the substrate specificity of coronavirus infectious bronchitis virus 3C-like proteinase.
Coronavirus (CoV) 3C-like proteinase (3CLpro), located in nonstructural protein 5 (nsp5), processes the replicase polyproteins 1a and 1ab (pp1a and pp1ab) at 11 specific sites to produce 12 mature nonstructural proteins (nsp5 to nsp16). Structural and biochemical studies suggest that a conserved Gln residue at the P1 position is absolutely required for efficient cleavage. Here, we investigate the effects of amino acid substitution at the P1 position of 3CLpro cleavage sites of infectious bronchitis virus (IBV) on the cleavage efficiency and viral replication by in vitro cleavage assays and reverse genetic approaches. Our results demonstrated that a P1-Asn substitution at the nsp4-5/Q2779, nsp5-6/Q3086, nsp7-8/Q3462, nsp8-9/Q3672, and nsp9-10/Q3783 sites, a P1-Glu substitution at the nsp8-9/Q3672 site, and a P1-His substitution at the nsp15-16/Q6327 site were tolerated and allowed recovery of infectious mutant viruses, albeit with variable degrees of growth defects. In contrast, a P1-Asn substitution at the nsp6-7/Q3379, nsp12-13/Q4868, nsp13-14/Q5468, and nsp14-15/Q5989 sites, as well as a P1-Pro substitution at the nsp15-16/Q6327 site, abolished 3CLpro-mediated cleavage at the corresponding position and blocked the recovery of infectious viruses. Analysis of the effects of these lethal mutations on RNA synthesis suggested that processing intermediates, such as the nsp6-7, nsp12-13, nsp13-14, nsp14-15, and nsp15-16 precursors, may function in negative-stranded genomic RNA replication, whereas mature proteins may be required for subgenomic RNA (sgRNA) transcription. More interestingly, a mutant 3CLpro with either a P166S or P166L mutation was selected when an IBV infectious cDNA clone carrying the Q6327N mutation at the nsp15-16 site was introduced into cells. Either of the two mutations was proved to enhance significantly the 3CLpro-mediated cleavage efficiency at the nsp15-16 site with a P1-Asn substitution and compensate for the detrimental effects on recovery of infectious virus.
Fang
Shouguo
S
School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551, Republic of Singapore.
Shen
Hongyuan
H
Wang
Jibin
J
Tay
Felicia P L
FP
Liu
Ding Xiang
DX
D000086042:3C Viral Proteases; D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D003546:Cysteine Endopeptidases / Q000235:genetics / Q000378:metabolism; D006801:Humans; D001351:Infectious bronchitis virus / Q000201:enzymology / Q000235:genetics; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D013379:Substrate Specificity / Q000235:genetics; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism
D014764:Viral Proteins; D003546:Cysteine Endopeptidases; D000086042:3C Viral Proteases
J Biol Chem. 2004 Jan 16;279(3):1637-42
14561748
Structure. 2004 Feb;12(2):341-53
14962394
J Gen Virol. 2003 Sep;84(Pt 9):2305-2315
12917450
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13190-5
14585926
J Virol. 1996 Mar;70(3):1923-30
8627718
J Virol. 2007 Jan;81(1):20-9
16928755
J Virol. 2004 Nov;78(22):12218-24
15507608
Virology. 2009 Jan 20;383(2):328-37
19022466
J Virol. 2009 Jul;83(13):6957-62
19386712
Biochemistry. 2004 Apr 20;43(15):4568-74
15078103
PLoS Pathog. 2005 Dec;1(4):e39
16341254
J Virol. 2008 Sep;82(17):8647-55
18562531
Virology. 2008 Sep 30;379(2):175-80
18678384
J Virol. 2007 Jul;81(13):7086-98
17428870
Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12694-9
15304651
J Gen Virol. 2002 Mar;83(Pt 3):595-599
11842254
J Virol. 2004 Jun;78(11):5619-32
15140959
J Virol. 1999 Mar;73(3):2027-37
9971783
Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122-6
3095828
J Biol Chem. 2008 Feb 8;283(6):3655-3664
18045871
Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3792-6
15007178
J Mol Biol. 2003 Aug 29;331(5):991-1004
12927536
J Virol. 2006 Apr;80(8):4157-67
16571831
Nucleic Acids Res. 2006;34(17):4816-25
16971454
J Virol. 2004 Jul;78(14):7833-8
15220459
Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):11892-7
16882730
Virology. 1998 Jul 5;246(2):288-97
9657947
J Virol. 2002 Jun;76(12):6257-67
12021359
J Biol Chem. 2002 Oct 18;277(42):39960-6
12163505
J Virol. 2007 Oct;81(19):10280-91
17634238
Nat Struct Mol Biol. 2005 Nov;12(11):980-6
16228002
J Virol. 2006 Aug;80(16):7902-8
16873247
J Mol Biol. 2005 Nov 11;353(5):1106-17
16216269
Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10012-7
15226499
J Gen Virol. 2000 Apr;81(Pt 4):853-79
10725411
J Biol Chem. 1996 Mar 1;271(9):4864-71
8617757
Virology. 1995 Apr 1;208(1):1-8
11831690
J Virol. 2003 Jan;77(2):1415-26
12502857
Biochem Biophys Res Commun. 2005 Apr 15;329(3):934-40
15752746
Nucleic Acids Res. 1989 Jun 26;17(12):4847-61
2526320
J Med Chem. 2006 Aug 10;49(16):4971-80
16884309
J Virol. 2007 Jun;81(12):6356-68
17392363
Curr Top Microbiol Immunol. 2005;287:57-94
15609509
J Virol. 2007 Nov;81(22):12135-44
17804504
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5108-13
16549795
Microbiol Immunol. 2005;49(10):899-908
16237267
J Virol. 2007 Feb;81(4):1574-85
17121802
FEBS Lett. 2003 Oct 23;553(3):451-6
14572668
Biochemistry. 2007 Jul 31;46(30):8744-52
17605471
EMBO J. 2006 Oct 18;25(20):4933-42
17024178
J Virol. 1997 Mar;71(3):1814-20
9032311
FEMS Microbiol Rev. 2006 Sep;30(5):760-73
16911043
Virology. 2007 Feb 5;358(1):136-47
16979681
Virology. 2001 Sep 30;288(2):212-22
11601893
Virology. 1998 Mar 15;242(2):288-302
9514967
Virology. 1998 Apr 10;243(2):388-95
9568037
J Virol. 2006 Aug;80(16):7909-17
16873248
Science. 2003 Jun 13;300(5626):1763-7
12746549
J Virol. 2006 Aug;80(16):7894-901
16873246
J Virol. 2007 Dec;81(24):13587-97
17898055
EMBO J. 2002 Jul 1;21(13):3213-24
12093723
J Virol. 1994 Sep;68(9):5772-80
8057459
J Virol. 2008 Aug;82(16):8071-84
18417574
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3484-9
19208801
J Virol. 2001 Jul;75(14):6676-81
11413334
Virology. 1995 Jun 1;209(2):420-7
7778277
PLoS Biol. 2005 Oct;3(10):e324
16128623
Cell. 2003 Jun 13;113(6):701-2
12809601
Virology. 2000 Jun 20;272(1):27-39
10873746
J Virol. 2008 Mar;82(5):2515-27
18094151
J Mol Biol. 2006 Aug 11;361(2):243-56
16828802
J Virol. 2007 Jun;81(12):6700-8
17409150
J Virol. 2008 Dec;82(24):12392-405
18842706
J Virol. 2006 Nov;80(21):10900-6
16928748